hydrogen has been researched along with celecoxib in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, AK; Dantuluri, AK; Puri, V | 1 |
| Cheng, G; Dwinell, MB; Kalyanaraman, B; McAllister, D; Tsai, S; Zielonka, J | 1 |
| Paul, S; Sun, CC | 1 |
| Boulas, P; Dun, J; Lin, Y; Osei-Yeboah, F; Sun, CC | 1 |
| Ahn, K; Connolly, P; Suarez, J; Tian, G; Zhang, Z | 1 |
5 other study(ies) available for hydrogen and celecoxib
| Article | Year |
|---|---|
Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
Topics: Capsules; Celecoxib; Cellulose; Chemistry, Pharmaceutical; Coated Materials, Biocompatible; Crystallization; Drug Compounding; Drug Stability; Excipients; Inulin; Meglumine; Pharmaceutical Preparations; Polyvinyl Alcohol; Polyvinyls; Povidone; Pyrazoles; Solubility; Sulfonamides; Temperature | 2012 |
Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Celecoxib; Cell Culture Techniques; Cell Growth Processes; Cell Line, Tumor; Deoxycytidine; Deoxyglucose; Doxorubicin; Energy Metabolism; Gemcitabine; Glycolysis; Humans; Hydrogen; Metformin; Mitochondria; Oxygen Consumption; Pancreatic Neoplasms; Pyrazoles; Sulfonamides | 2014 |
The suitability of common compressibility equations for characterizing plasticity of diverse powders.
Topics: Algorithms; Calcium Phosphates; Celecoxib; Cellulose; Compressive Strength; Excipients; Hardness; Ibuprofen; Lactose; Mannitol; Powders; Stearic Acids | 2017 |
A systematic evaluation of dual functionality of sodium lauryl sulfate as a tablet lubricant and wetting enhancer.
Topics: Celecoxib; Cellulose; Lactose; Lubricants; Sodium Dodecyl Sulfate; Stearic Acids; Surface-Active Agents; Tablets; Wettability | 2018 |
Potent Phenylpyridine and Oxodihydrofuran Inhibitors of Cyclooxygenase-2: Optimization toward a Long Residence Time with Balanced Internal Energetics.
Topics: Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Discovery; Enzyme Assays; Etoricoxib; Fluorescence; Furans; Humans; Hydrogen; Kinetics; Mass Spectrometry; Models, Theoretical; Oxygen; Pyrazoles; Pyridines; Thermodynamics; Time Factors | 2021 |